Top Cited Articles
Acceptance Rate:
15%
Time to first decision with review:
46 days*
Impact Factor:
10
Impact Factor rank (JCR):
6/65
Citescore:
14.3
Total Altmetric mentions:
5,774
'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19
Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of aggregate data from randomised controlled trials
Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort
COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms
Cigarette smoke exposure and alveolar macrophages: mechanisms for lung disease
Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis
Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length
Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort
Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19
Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study
Neutrophils in asthma: the good, the bad and the bacteria
A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial
Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS
A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations
Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis
Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score
Association of the dysfunctional placentation endotype of prematurity with bronchopulmonary dysplasia: a systematic review, meta-analysis and meta-regression
Telerehabilitation for chronic respiratory disease: a randomised controlled equivalence trial
Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19
Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide